Protagonist Therapeutics ... (PTGX)
44.38
-1.77 (-3.85%)
At close: Apr 24, 2025, 1:55 PM
13F Institute Ownership
Total Institutes of 247 in Protagonist Therapeutics expanded their positions with an increase of 0 investors compared to the previous quarter. An additional 1.61M shares, as total invested capital declined by $331.93M with ownership percentage increasing from 99.79% to 102.40%.
Options Activity
Institutions are holding Calls/Puts contracts nearly balanced, indicating a neutral sentiment.
Put/Call 0.968
0.97
Call Flow 224,800
51%
Put Flow 217,700
49%
Top Shareholders
| Institute | Ownership | Shares | Shares % Change | Market Value | Portfolio |
|---|---|---|---|---|---|
| Blackrock, Inc. | 16.00% | 9.88M | -3.32% | 381.55M | < 0.01% |
| Farallon Capital Management Ll... | 9.60% | 5.93M | +1.18% | 228.9M | 1.16% |
| Rtw Investments, LP | 8.90% | 5.5M | +1.33% | 212.24M | 3.21% |
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.